Posts in tag

EpimAb

Technology

SHANGHAI–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Jerry Su, Ph.D. as the Chief Technology Officer of EpimAb. Dr. Su joined EpimAb in December 2019 as Senior VP, CMC and led the completion of EpimAb’s early CMC development facility in Suzhou BioBay. In this newly created …